Activist investor Ananym Capital Management is urging healthcare products distributor Henry Schein to refresh its board, cut ...

Henry Schein (NASDAQ:HSIC) rose 7.4% amid a report that an activist investor has taken a stake and is pushing for the dental ...

Activist Ananym Capital Management is urging Henry Schein (HSIC) to refresh its board, cut costs, tackle succession planning and consider selling its medical distribution business, Svea Herbst-Bayliss ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $79.5, a high estimate of $82.00, ...

Despite modest sales growth, Henry Schein Inc (HSIC) boosts EPS guidance and expands its global e-commerce platform.

On Tuesday, Henry Schein Inc. (NASDAQ:HSIC) reported a third-quarter adjusted EPS of $1.22, down 7.6% year-over-year, beating ...

Henry Schein ( (HSIC) ) has released its Q3 earnings. Here is a breakdown of the information Henry Schein presented to its investors. Henry ...

Good morning, ladies and gentlemen, and welcome to Henry Schein's Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a ...

The dental supplies firm raised the lower end of its 2024 adjusted earnings projection, and now anticipates a range between $4.74 and $4.82 a share, compared with the prior $4.70-to-$4.82 a share ...

Analysts' ratings for Henry Schein (NASDAQ:HSIC ... products and services primarily to office-based dental and medical practitioners, as well as alternate sites of care. The company operates ...

Pfizer, General Motors, and Centene are among those that are still cheap despite impressive earnings beats. We sell different types of products and services to both investment professionals and ...